A Quick Transition To Late-Stage Clinical Trials
“Moving into Phase 3 not only expands the resources you need internally, but some things require a much larger amount of capital, and often a...
Stay updated with breaking news from Wayne Koberstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
“Moving into Phase 3 not only expands the resources you need internally, but some things require a much larger amount of capital, and often a...
Orca Bio is creating a new cell therapy aimed at bringing rebirth to stem-cell transplantation.
Kriya’s firm commitment to build or bring all key functions in house may be unusual for such a young enterprise, but it has been consistent...
Vor Bio’s story, for all of its uniqueness, can teach important lessons in many different quarters, involving everything from mundane tactics...
KaliVir Immunotherapeutics is engineering oncolytic viruses with novel transgenes, and joining them to other immunotherapies, to defeat cancer and...